Everolimus in anaplastic thyroid cancer: A case series.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e18112
Abstract: e18112Background: Anaplastic thyroid cancer (ATC) accounts for 1-3% of all thyroid cancers. It is extremely aggressive and mortality remains high. No systemic standard of care exists for patients w... read more here.
Keywords: anaplastic thyroid; cancer case; everolimus anaplastic; thyroid cancer ... See more keywords